Actively Recruiting
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Led by Aesculap AG · Updated on 2026-03-31
200
Participants Needed
4
Research Sites
258 weeks
Total Duration
On this page
Sponsors
A
Aesculap AG
Lead Sponsor
R
Raylytic GmbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications
CONDITIONS
Official Title
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is minimum 18 years old
- Informed Consent in the documentation of clinical and radiological results
- Patient has indication according to Instructions for Use (IFU)
- Patient is not pregnant
You will not qualify if you...
- Patient's clear unability or unwillingness to participate in follow-up examinations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Krankenhaus Ludmillenstift Meppen
Meppen, Lower Saxony, Germany, 49716
Not Yet Recruiting
2
Städtisches Klinikum Dresden
Dresden, Saxony, Germany, 01076
Not Yet Recruiting
3
Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale
Halle, Saxony-Anhalt, Germany, 06112
Actively Recruiting
4
Schön Klinik Hamburg Eilbek
Hamburg, Germany, 22081
Active, Not Recruiting
Research Team
S
Sarah Mattes
CONTACT
S
Stefan Maenz, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here